This inventor holds 2 USPTO granted patents. Top assignees: Focal, Inc., Genzyme Corporation. Active years: 1998-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2004
Title: Innovations of Inventor Keith Baker
Introduction
Keith Baker is an accomplished inventor based in Lynn, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of adhesion reduction. With a total of 2 patents, his work focuses on innovative solutions to prevent undesirable tissue adhesion.
Latest Patents
Baker's latest patents include methods for the reduction of adhesions using controlled delivery of active oxygen inhibitors. These patents detail how superoxide dismutase (SOD) and other active oxygen inhibitors can be directly applied in combination with barrier materials at local sites of tissue injury. This approach aims to prevent or decrease the formation of adhesions and undesirable cell proliferation. Preferred barrier materials are polymeric hydrogels that provide controlled release of active oxygen inhibitors, which are directly applied to the affected tissue. Examples from his research demonstrate the effects of SOD on pelvic adhesions in rats when administered through intraperitoneal bolus and localized sustained release from a topically applied hydrogel system.
Career Highlights
Throughout his career, Keith Baker has worked with notable companies such as Focal, Inc. and Genzyme Corporation. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.
Collaborations
Baker has collaborated with various professionals in his field, including his coworker Arthur J. Coury. Their joint efforts have further advanced the research and development of adhesion reduction technologies.
Conclusion
Keith Baker's innovative work in the field of adhesion reduction showcases his dedication to improving medical outcomes. His patents and collaborations reflect a commitment to advancing healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

